Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Change in Securities (2016 - 2018)

Fortress Biotech has reported Change in Securities over the past 3 years, most recently at $16000.0 for Q3 2018.

  • For Q3 2018, Change in Securities rose 120.78% year-over-year to $16000.0; the TTM value through Sep 2018 reached $24000.0, changed N/A, while the annual FY2017 figure was -$147000.0, 149.33% down from the prior year.
  • Change in Securities for Q3 2018 was $16000.0 at Fortress Biotech, up from $8000.0 in the prior quarter.
  • Over five years, Change in Securities peaked at $298000.0 in Q4 2016 and troughed at -$297000.0 in Q1 2017.
  • A 3-year average of $3000.0 and a median of $12000.0 in 2018 define the central range for Change in Securities.
  • On a YoY basis, Change in Securities climbed as much as 120.78% in 2018 and fell as far as 89.47% in 2018.
  • Year by year, Change in Securities stood at $298000.0 in 2016, then crashed by 49.33% to $151000.0 in 2017, then crashed by 89.4% to $16000.0 in 2018.
  • Business Quant data shows Change in Securities for FBIO at $16000.0 in Q3 2018, $8000.0 in Q2 2018, and -$151000.0 in Q1 2018.